🐜
|
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
15 auth.
S. Appel-Cresswell,
C. Vilariño-Gúell,
M. Encarnacion,
Holly E. Sherman,
Irene Yu,
Brinda Shah,
David Weir,
Christina Thompson,
C. Szu‐Tu,
J. Trinh,
...
J. Aasly,
A. Rajput,
A. Rajput,
A. Stoessl,
M. Farrer
|
9 |
2013 |
9 🐜
|
🐜
|
DNAJC13 mutations in Parkinson disease.
40 auth.
C. Vilariño-Güell,
A. Rajput,
A. Milnerwood,
Brinda Shah,
C. Szu‐Tu,
J. Trinh,
Irene Yu,
M. Encarnacion,
Lise N. Munsie,
L. Tapia,
E. Gustavsson,
Patrick Chou,
Igor Tatarnikov,
Daniel M. Evans,
F. Pishotta,
...
Mattia Volta,
Dayne A Beccano-Kelly,
Christina Thompson,
Michelle K. Lin,
Holly E. Sherman,
Heather Han,
Bruce L. Guenther,
W. Wasserman,
V. Bernard,
C. Ross,
S. Appel-Cresswell,
A. Stoessl,
C. Robinson,
D. Dickson,
O. Ross,
Z. Wszolek,
J. Aasly,
R. Wu,
F. Hentati,
R. Gibson,
P. McPherson,
M. Girard,
M. Rajput,
A. Rajput,
M. Farrer
|
8 |
2014 |
8 🐜
|
🐬
|
Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension
Jennifer D. Reid,
Daniel T. Holmes,
D. Randal Mason,
Brinda Shah,
Christoph H. Borchers
|
6 |
2010 |
6 🐬
|
🐜
|
STX6 rs1411478 is not associated with increased risk of Parkinson's disease.
12 auth.
J. Trinh,
C. Vilariño-Güell,
Alan Donald,
Brinda Shah,
Irene Yu,
C. Szu‐Tu,
...
J. Aasly,
R. Wu,
F. Hentati,
A. Rajput,
A. Rajput,
M. Farrer
|
4 |
2013 |
4 🐜
|
🦁
|
Developing an iMALDI method.
Brinda Shah,
Jennifer D. Reid,
M. Kuzyk,
C. Parker,
C. Borchers
|
3 |
2013 |
3 🦁
|
🦁
|
Emerging mass spectrometry-based technologies for analyses of chromatin changes: analysis of histones and histone modifications.
Brinda Shah,
Rachel L. Kozlowski,
Jun Han,
C. Borchers
|
2 |
2011 |
2 🦁
|
🦁
|
Toll-like receptor 4 activity promotes immunosuppression in the cutaneous T-cell lymphoma microenvironment
Brinda Shah,
E. Correia,
P. Porcu,
N. Nikbakht
|
0 |
2021 |
0 🦁
|
🦁
|
The development of an antibody affinity enrichment and mass spectrometry-based assay (iMALDI) for the characterization of EGFR and EGFR isoforms from human brain cancer tissue
Brinda Shah
|
0 |
2011 |
0 🦁
|
🐜
|
Abstract 4053: A mesothelin targeting chimeric antigen receptor macrophage (CAR-M) for solid tumor immunotherapy: pre-clinical development of CT-1119
12 auth.
N. Anderson,
Brinda Shah,
Alison Worth,
R. Gabbasov,
Brett Menchel,
Kerri Ciccaglione,
...
D. Blumenthal,
S. Pierini,
S. DeLong,
S. Abramson,
T. Condamine,
M. Klichinsky
|
0 |
2023 |
0 🐜
|